Jill Moormeier is an Oncology physician affiliated with University of Missouri–Kansas City. OpenAlex indexes 38 publications with 624 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2301 Holmes St
Kansas City, MO 641082640
Telephone
816-404-4375Provider last certified this registry record 2 Dec 2020.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Spark Therapeutics, Inc.Program year20243 payments
- ABBVIE INC.Program year20242 payments
- Spark Therapeutics, Inc.Program year20239 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
44%Aromatase Inhibitor15.5%Anastrozole78%Letrozole22%Part D<11 patientsAndrogen Receptor Inhibitor9.8%Xtandi100%Part D<11 patients+ 4 more classes in this area
Nervous system
28.4%Opioid Agonist24.7%Oxycodone Hcl73%Morphine Sulfate Er14%Oxycodone-Acetaminophen13%Part D<11 patientsTricyclic Antidepressant3.7%Nortriptyline Hcl100%Part D<11 patientsMetabolism & gastrointestinal
12.1%Corticosteroid7.2%Prednisone100%Part D<11 patientsSerotonin-3 Receptor Antagonist4.9%Ondansetron Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Clinical Course of Repeated Supratherapeutic Ingestion of Acetaminophen
Clinical Case Reports and Studies
2024 - OC 20.3 Improved Joint Health After Gene Therapy with Dirloctocogene Samoparvovec (SPK-8011) in People with Hemophilia A
Research and Practice in Thrombosis and Haemostasis
2023
Similar KOLs
Other experts from the same institution or the same specialty.
John Spertus, MD
University of Missouri–Kansas City
Anand Rajpara, MD
University of Missouri–Kansas City
Barry Rutherford, MD
University of Missouri–Kansas City
Lamont Weide, MD, PhD, FACE
University of Missouri–Kansas City
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”